Show simple item record

dc.contributor.authorNorris, T.
dc.date.accessioned2021-02-22T11:37:08Z
dc.date.available2021-02-22T11:37:08Z
dc.date.issued2021-01
dc.identifier.citationMcGrane J et al. The Impact of Treatment Crossover and Prostate-specific Antigen Flare with Enzalutamide and Abiraterone in Metastatic Castrate Resistant Prostate Cancer. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):e92. doi: 10.1016/j.clon.2020.07.009. Epub 2020 Jul 29.en_US
dc.identifier.pmid32739115
dc.identifier.doi10.1016/j.clon.2020.07.009
dc.identifier.urihttps://rde.dspace-express.com/handle/11287/621623
dc.language.isoenen_US
dc.publisherElsevier Scienceen_US
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0936-6555(20)30291-0en_US
dc.rights© 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.en_US
dc.subjectProstate Canceren_US
dc.subjectTreatment Crossoveren_US
dc.subjectAntigen Flareen_US
dc.subjectEnzalutamideen_US
dc.subjectAbirateroneen_US
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.en_US
dc.titleThe Impact of Treatment Crossover and Prostate-specific Antigen Flare with Enzalutamide and Abiraterone in Metastatic Castrate Resistant Prostate Canceren_US
dc.typeLetteren_US
dc.identifier.journalClinical Oncologyen_US
dc.type.versionPublisheden_US
dc.description.admin-notepublished version, accepted version (12 month embargo)en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record